Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides

This study is ongoing, but not recruiting participants.

Study NCT00074087 Information provided by National Cancer Institute (NCI)

First Received: December 10, 2003 Last Updated: November 26, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given